People: Agenus Inc (AGEN.PH)

AGEN.PH on Philadelphia Stock Exchange

3.15USD
25 Aug 2014
Price Change (% chg)

$-0.01 (-0.32%)
Prev Close
$3.12
Open
--
Day's High
$3.16
Day's Low
$3.14
Volume
2,178
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

Malik, Shahzad 

Brief Biography

Dr. Shahzad Malik, M.D., is Independent Director of Agenus Inc. Dr. Malik is a General Partner at Advent Venture Partners, a position he has held since 1999. Dr. Malik brings to our Board historical knowledge of 4-Antibody’s operations, the business we acquired earlier this year, as well as broad experiences in the life sciences and medical industries. During his time with Advent, he has been actively involved with numerous investments in Europe and the United States in the biopharmaceutical and medical device arenas in a variety of therapeutic areas. A number of these companies that Advent invested in are now publicly traded or have been acquired. Dr. Malik currently serves on the Board of Directors of Conatus Pharmaceuticals, Inc. and Versartis, Inc., both life sciences companies. Prior to joining Advent, Dr. Malik spent six years practicing medicine before joining the London office of management consultants McKinsey & Company. While there he served international clients in the Healthcare and Investment Banking sectors. Dr. Malik holds an M.A. from Oxford University and a M.D. from Cambridge University. He subsequently specialized in interventional cardiology while also pursuing research interests in heart muscle disorders both in the clinic and basic science laboratory.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Garo Armen

1,589,170

Christine Klaskin

437,697

Robert Stein

--

Karen Valentine

551,954

Ozer Baysal

587,802

Timothy Wright

--
As Of 30 Dec 2013
Search Stocks